BARBANTI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 12.373
AS - Asia 10.939
EU - Europa 8.458
SA - Sud America 1.601
AF - Africa 90
OC - Oceania 13
Totale 33.474
Nazione #
US - Stati Uniti d'America 12.232
HK - Hong Kong 7.859
IE - Irlanda 5.956
SG - Singapore 2.026
BR - Brasile 1.363
GB - Regno Unito 913
CH - Svizzera 406
VN - Vietnam 353
FI - Finlandia 326
IT - Italia 272
DE - Germania 215
CN - Cina 204
TR - Turchia 134
AR - Argentina 95
FR - Francia 68
CA - Canada 63
BD - Bangladesh 59
IN - India 59
MX - Messico 56
EC - Ecuador 47
EE - Estonia 40
PL - Polonia 40
NL - Olanda 39
CZ - Repubblica Ceca 36
RU - Federazione Russa 35
ID - Indonesia 32
ZA - Sudafrica 29
CO - Colombia 28
KR - Corea 26
UZ - Uzbekistan 26
IQ - Iraq 23
JP - Giappone 21
PK - Pakistan 20
AT - Austria 19
PY - Paraguay 18
SE - Svezia 18
UA - Ucraina 17
ES - Italia 15
UY - Uruguay 15
CL - Cile 14
EG - Egitto 13
KE - Kenya 13
MA - Marocco 13
VE - Venezuela 12
AU - Australia 11
IR - Iran 11
IL - Israele 9
PE - Perù 8
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
JO - Giordania 7
BG - Bulgaria 6
LT - Lituania 6
LV - Lettonia 6
NP - Nepal 6
PH - Filippine 6
SA - Arabia Saudita 6
TN - Tunisia 5
AZ - Azerbaigian 4
BE - Belgio 4
CR - Costa Rica 4
DZ - Algeria 4
ET - Etiopia 4
KG - Kirghizistan 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
BB - Barbados 3
BH - Bahrain 3
BY - Bielorussia 3
JM - Giamaica 3
KZ - Kazakistan 3
MY - Malesia 3
TT - Trinidad e Tobago 3
UG - Uganda 3
AL - Albania 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HU - Ungheria 2
LB - Libano 2
LY - Libia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BO - Bolivia 1
GD - Grenada 1
GE - Georgia 1
GM - Gambi 1
GR - Grecia 1
HR - Croazia 1
HT - Haiti 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
Totale 33.464
Città #
Hong Kong 7.858
Dallas 6.292
Dublin 5.918
Ashburn 1.216
Singapore 921
London 833
Boardman 807
San Jose 669
Santa Clara 434
Zurich 406
The Dalles 389
Helsinki 314
Washington 197
Ho Chi Minh City 126
São Paulo 118
Istanbul 110
Los Angeles 108
Hanoi 80
Assago 76
Munich 72
Rio de Janeiro 48
Chicago 43
San Francisco 42
New York 39
Belo Horizonte 37
Warsaw 34
Milan 30
Frankfurt am Main 28
Montreal 28
Council Bluffs 27
Brasília 26
Brooklyn 26
Seattle 26
Seoul 25
Tashkent 22
Brno 21
Porto Alegre 20
Amsterdam 19
Guayaquil 19
Mexico City 19
Salvador 18
Stockholm 18
Atlanta 17
Beijing 17
Hillsboro 17
Johannesburg 17
Boston 16
Curitiba 16
Quito 15
Shanghai 15
Catania 14
Da Nang 14
Haiphong 14
Montevideo 14
Olomouc 14
Tokyo 14
Campinas 13
Hải Dương 13
Rome 13
Chennai 12
Falkenstein 12
Guarulhos 12
Nairobi 12
Buenos Aires 11
Dhaka 11
Duque de Caxias 11
Goiânia 11
Cipolletti 10
Thái Bình 10
Turku 10
Bexley 9
Clifton 9
Düsseldorf 9
Fortaleza 9
Manchester 9
Phoenix 9
Piscataway 9
Guangzhou 8
Joinville 8
Manaus 8
Osasco 8
Ribeirão Preto 8
Tanta 8
Tappahannock 8
Thái Nguyên 8
Amman 7
Biên Hòa 7
Columbus 7
Denver 7
Florianópolis 7
Genoa 7
Jakarta 7
Karachi 7
Maceió 7
Mumbai 7
Ottawa 7
Santo André 7
Sapiranga 7
Sumaré 7
São José dos Campos 7
Totale 28.166
Nome #
1-Year Outcomes After Transfemoral Transcatheter or Surgical Aortic Valve Replacement: Results From the Italian OBSERVANT Study 2.453
European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease 1.169
Prosthesis choice for transcatheter aortic valve replacement: Improved outcomes with the adoption of a patient-specific transcatheter heart valve selection algorithm 961
Transcatheter versus surgical aortic valve replacement in patients with morbid obesity: a multicentre propensity score-matched analysis 958
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation 713
Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry 643
Embolic protection device in a patient with large left ventricular thrombus undergoing transcatheter aortic valve replacement 558
Medical Comorbidities in Alzheimer's Disease: An Autopsy Confirmed Study with a Focus on Sex-Differences? 539
Predicting neocommissural orientation during TAVI workup 505
Transcathether aortic valve implantation with the new repositionable self-expandable Evolut R versus CoreValve system: A case-matched comparison 489
Aortic angle distribution and predictors of horizontal aorta in patients undergoing transcatheter aortic valve replacement 432
Development and validation of the D-PACE scoring system to predict delayed high-grade conduction disturbances after transcatheter aortic valve implantation 379
Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation 375
Le nuove frontiere della cardiologia interventistica strutturale 350
Transcatheter or surgical treatment of severe aortic stenosis and coronary artery disease: A comparative analysis from the Italian OBSERVANT study 139
A Risk Model for Prediction of 1-Year Mortality in Patients Undergoing MitraClip Implantation 131
A novel, comprehensive tool for predicting 30-day mortality after surgical aortic valve replacement 131
30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study 129
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 126
Acute kidney injury after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis: results from a large multicentre Italian research project 124
3-year outcomes of self-expanding Corevalve prosthesis - The Italian Registry 123
[Transcatheter aortic valve implantation: are we ready? If so, for which patients? Is it sustainable? The interventional cardiologist's point of view] 117
Antithrombotic therapy following transcatheter aortic valve implantation: what challenge do we face? 116
Transcatheter aortic valve replacement in obese patients: procedural vascular complications with the trans-femoral and trans-carotid access routes 116
A novel, comprehensive tool for predicting 30-day mortality after surgical aortic valve replacement 115
Transcatheter mitral valve implantation: CardiAQ 114
A minimalistic approach for transfemoral transcatheter aortic valve implantation therapy: a prospective “real-world” study 105
Late Degeneration of Transcatheter Aortic Valves: Pathogenesis and Management 104
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation) 102
Accuracy of intracardiac echocardiography for aortic root assessment in patients undergoing transcatheter aortic valve implantation 102
5-Year Outcomes After Transcatheter Aortic Valve Implantation With CoreValve Prosthesis 101
Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis 100
Transcatheter aortic valve-in-valve implantation to treat aortic para-valvular regurgitation after TAVI 100
Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation 99
Evaluation of current practices in transcatheter aortic valve implantation: The WRITTEN (WoRldwIde TAVI ExperieNce) survey 99
Procedural outcomes of the 34 mm EvolutR Transcatheter valve in a real-world population insights from the HORSE multicenter collaborative registry 98
5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction 97
Clinical outcomes of transcatheter aortic valve implantation in patients younger than 70 years rejected for surgery: the AMTRAC registry 97
Transcatheter Mitral Valve Implantation: CardiAQ-Edwards 94
Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation 94
Acute left atrial spontaneous echocardiographic contrast and suspicious thrombus formation following mitral regurgitation reduction with the MitraClip system 93
Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration 92
Impact of chronic kidney disease on outcomes after percutaneous mitral valve repair with the MitraClip system: insights from the GRASP registry 91
Acute and long-term (2-years) clinical outcomes of the CoreValve 31mm in large aortic annuli: A multicenter study 90
[Evolution of transcatheter aortic valve implantation from a high-volume Italian center: report of 2058 procedures over 15-year experience] 90
Managing complications after transcatheter aortic valve implantation 89
ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases 89
Functional and metabolic frailty predicts mortality in patients undergoing TAVI: Insights from the OBSERVANT II study 88
CharActeristics, sizing anD outcomes of stenotic, tapered, rapHe-type bicuspid aOrtic valves treated with trans-catheter device implantation: Insights the AD HOC registry 86
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 86
Early detection of transcatheter heart valve dysfunction 85
Transcatheter aortic valve replacement with the self-expanding ACURATE Neo2 in patients with horizontal aorta: Insights from the ITAL-neo registry 85
A gender based analysis of predictors of all cause death after transcatheter aortic valve implantation 85
[First results from the OBSERVANT II study: clinical characteristics of patients with aortic stenosis undergoing transcatheter treatment with new generation devices] 85
Sex Differences in Transfemoral Transcatheter Aortic Valve Replacement 83
Early and Mid-Term Outcomes of Transcatheter Aortic Valve Replacement Using the New Generation Self-Expanding Corevalve Evolut R Device 83
Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to high-risk transcatheter aortic valve implantation 83
Early and late outcomes after transcatheter versus surgical aortic valve replacement in obese patients 82
Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve 81
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 80
Clinical outcomes in women and men with small aortic annuli undergoing transcatheter aortic valve implantation: A multicenter, retrospective, propensity score-matched comparison 80
Predictors of pacemaker implantation after transcatheter aortic valve implantation according to kind of prosthesis and risk profile: a systematic review and contemporary meta-analysis 80
Cerebral embolization during transcatheter aortic valve implantation 80
One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry) 80
Safety and efficacy of drug eluting stents in patients with spontaneous coronary artery dissection 80
Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Patients With Chronic Kidney Disease Stages 3b to 5 79
Prespecified Risk Criteria Facilitate Adequate Discharge and Long-Term Outcomes After Transfemoral Transcatheter Aortic Valve Implantation 79
The Helio transcatheter aortic dock for patients with aortic regurgitation 79
Early Adverse Impact of Transfusion After Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the TRITAVI Registry 79
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation 79
Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation 78
Early and Midterm Outcome of Propensity-Matched Intermediate-Risk Patients Aged ≥80 Years With Aortic Stenosis Undergoing Surgical or Transcatheter Aortic Valve Replacement (from the Italian Multicenter OBSERVANT Study) 78
Long-term outcomes of concomitant transcatheter aortic valve implantation and percutaneous coronary intervention 77
Early and mid-term outcome of patients with low-flow-low-gradient aortic stenosis treated with newer-generation transcatheter aortic valves 77
Transcatheter aortic valve replacement with new-generation devices: A systematic review and meta-analysis 76
Bioprosthetic valves for transcatheter aortic valve replacement 76
OBSERVANT II: OBservational Study of Effectiveness of transcatheter aortic valve implantation with new geneRation deVices for severe Aortic steNosis Treatment. Study protocol 76
Pre-Defining Optimal C-Arm Position for TAVI With CT-Scan Using a Free Software 75
Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement 75
Predictors and safety of next-day discharge in patients undergoing transfemoral transcatheter aortic valve implantation 75
Management of severe stenosis controversies and promises 75
Real-World Multiple Comparison of Transcatheter Aortic Valves: Insights From the Multicenter OBSERVANT II Study 75
Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry 75
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2 75
Transcatheter aortic valve implantation compared with surgical aortic valve replacement in patients with anaemia 74
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 74
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement 74
Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death 73
Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement 73
Outcomes of Patients Undergoing Balloon Aortic Valvuloplasty in the TAVI Era: A Multicenter Registry 73
One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry 73
Unusual interatrial membrane in the left atrium: A newer obstacle for transseptal-based percutaneous mitral valve repair techniques? 73
Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation 72
Comparison of Early and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients with New York Heart Association Functional Class IV to those in Class III and Less 72
One-Year Outcomes after Surgical versus Transcatheter Aortic Valve Replacement with Newer Generation Devices 72
The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study 72
Balloon-Expandable versus Self-Expandable Valves in Transcatheter Aortic Valve Implantation: Complications and Outcomes from a Large International Patient Cohort 72
Early Discharge After Transcatheter Aortic Valve Replacement: Mature Times 72
Perivalvular Extension of Infective Endocarditis After Transcatheter Aortic Valve Replacement 71
Clinical Outcomes and Prognosis Markers of Patients With Liver Disease Undergoing Transcatheter Aortic Valve Replacement: A Propensity Score-Matched Analysis 71
Totale 18.142
Categoria #
all - tutte 152.080
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 152.080


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231.386 0 0 0 0 0 0 0 0 0 269 817 300
2023/20247.574 278 707 401 540 1.311 1.170 1.228 492 439 431 249 328
2024/202514.265 1.491 249 544 152 610 681 7.367 307 978 692 766 428
2025/202610.698 870 3.391 3.663 1.212 323 469 770 0 0 0 0 0
Totale 33.923